Publication date: July 07, 2026
| The draft Act of April 13, 2026, amending the Act on Food and Nutrition Safety will enter into force six months after its publication. The new regulations primarily impact producers, importers, distributors, and sellers of dietary supplements – both in traditional and online channels. Below, we present the real changes to your business. |
Publication date: July 07, 2026
We are delighted to share an important milestone in the continued development of KG Legal’s Data, AI & Cybersecurity Desk.
It has been a great honour to serve as the exclusive expert contributors for Poland to the OneTrust DataGuidance Privacy Overview – Poland, one of the world’s leading professional legal compliance resources relied upon by in-house counsel, privacy professionals, compliance officers, multinational organisations and technology companies operating across multiple jurisdictions.
Publication date: July 07, 2026
The Polish dietary supplements market is facing the most significant regulatory overhaul in years. The draft amendment to the Act on Food and Nutrition Safety and the Act on the State Sanitary Inspectorate introduces a series of far-reaching changes that will substantially alter the way supplements are notified, monitored, advertised, and supervised in Poland. While the reform does not formally introduce a pre-market authorization system, it undeniably strengthens the position of regulatory authorities and increases the compliance burden imposed on businesses operating in the sector.
Publication date: June 18, 2026
On June 19, 2026, representatives of our law firm will participate in the Data Science Summit AI Edition 2026, which will be held at the Palace of Culture and Science in Warsaw. For many years, the event has been one of the most important technology conferences in Central and Eastern Europe, bringing together specialists responsible for the development and implementation of the most advanced solutions based on artificial intelligence, machine learning, and data analysis. It provides a meeting place for the business, technology, scientific, and administrative communities—a space where implementation practice meets regulatory and strategic reflection.
Link to the event: https://ml.dssconf.pl/#agenda
This year’s edition focuses on the most important directions of development of modern artificial intelligence, including, among others, generative AI ( Generative AI), large language models (LLM), GPT systems, AI agents, Agent-to-Agent (A2A) architectures, Context Model Protocol (MCP), reinforcement learning, computer vision, predictive analytics, MLOps, LLMOps, AI governance and broadly understood data-driven business transformation.
The conference is aimed at data scientists, AI experts, data engineers, IT system architects, programmers, cybersecurity specialists, digital transformation leaders, product development managers, public administration representatives, and executives of enterprises implementing AI-based solutions. Speakers will include representatives of global technology companies, international corporations, financial institutions, telecommunications operators, energy companies, research and development organizations, academia, and technology startups – including AI directors, chief system architects, digital transformation leaders, scientists, AI engineers, MLOps experts, cybersecurity specialists, and managers responsible for implementing technological innovations.
The event is distinguished by its practical nature. The program focuses not only on presenting technological innovations, but primarily on showcasing real-world implementations already in place in businesses, public administration, the financial and energy sectors, e-commerce, telecommunications, healthcare, and industry.
Publication date: October 07, 2025
Pharmacovigilance under Polish law
The purpose of an inspection of the pharmacovigilance system for medicinal products intended for human use (pharmacovigilance inspection) is to verify how the marketing authorization holder for medicinal products is fulfilling its obligations regarding the pharmacovigilance system imposed by Polish and European Union law.
